126 related articles for article (PubMed ID: 38759643)
1. Variability in cell division among anatomical sites shapes Escherichia coli antibiotic survival in a urinary tract infection mouse model.
Amoura A; Pistien C; Chaligné C; Dion S; Magnan M; Bridier-Nahmias A; Baron A; Chau F; Bourgogne E; Le M; Denamur E; Ingersoll MA; Fantin B; Lefort A; El Meouche I
Cell Host Microbe; 2024 Jun; 32(6):900-912.e4. PubMed ID: 38759643
[TBL] [Abstract][Full Text] [Related]
2. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
[TBL] [Abstract][Full Text] [Related]
3. Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model.
Kerrn MB; Frimodt-Møller N; Espersen F
Antimicrob Agents Chemother; 2003 Mar; 47(3):1002-9. PubMed ID: 12604534
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
mBio; 2012; 3(1):. PubMed ID: 22318320
[TBL] [Abstract][Full Text] [Related]
5. Viable but nonculturable uropathogenic bacteria are present in the mouse urinary tract following urinary tract infection and antibiotic therapy.
Rivers B; Steck TR
Urol Res; 2001 Feb; 29(1):60-6. PubMed ID: 11310218
[TBL] [Abstract][Full Text] [Related]
6. Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
Lepeule R; Ruppé E; Le P; Massias L; Chau F; Nucci A; Lefort A; Fantin B
Antimicrob Agents Chemother; 2012 Mar; 56(3):1376-81. PubMed ID: 22214774
[TBL] [Abstract][Full Text] [Related]
7. Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.
Hvidberg H; Struve C; Krogfelt KA; Christensen N; Rasmussen SN; Frimodt-Møller N
Antimicrob Agents Chemother; 2000 Jan; 44(1):156-63. PubMed ID: 10602738
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli.
Rippere-Lampe KE; O'Brien AD; Conran R; Lockman HA
Infect Immun; 2001 Jun; 69(6):3954-64. PubMed ID: 11349064
[TBL] [Abstract][Full Text] [Related]
9. VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic
Sawant NV; Chang SS; Pandit KA; Khekare P; Warner WR; Zimmern PE; De Nisco NJ
Microbiol Spectr; 2024 Mar; 12(3):e0271223. PubMed ID: 38240572
[TBL] [Abstract][Full Text] [Related]
10. Dynamic persistence of UPEC intracellular bacterial communities in a human bladder-chip model of urinary tract infection.
Sharma K; Dhar N; Thacker VV; Simonet TM; Signorino-Gelo F; Knott GW; McKinney JD
Elife; 2021 Jul; 10():. PubMed ID: 34219648
[TBL] [Abstract][Full Text] [Related]
11. Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.
Schilling JD; Lorenz RG; Hultgren SJ
Infect Immun; 2002 Dec; 70(12):7042-9. PubMed ID: 12438384
[TBL] [Abstract][Full Text] [Related]
12. Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women.
Ejrnaes K; Sandvang D; Lundgren B; Ferry S; Holm S; Monsen T; Lundholm R; Frimodt-Moller N
J Clin Microbiol; 2006 May; 44(5):1776-81. PubMed ID: 16672406
[TBL] [Abstract][Full Text] [Related]
13. Stratification by demographic and clinical data of the antibiotic susceptibility of Escherichia coli from urinary tract infections of the community.
Grados MC; Thuissard IJ; Alós JI
Aten Primaria; 2019 Oct; 51(8):494-498. PubMed ID: 30104087
[TBL] [Abstract][Full Text] [Related]
14. Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity.
Goneau LW; Hannan TJ; MacPhee RA; Schwartz DJ; Macklaim JM; Gloor GB; Razvi H; Reid G; Hultgren SJ; Burton JP
mBio; 2015 Mar; 6(2):. PubMed ID: 25827417
[TBL] [Abstract][Full Text] [Related]
15. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Blango MG; Mulvey MA
Antimicrob Agents Chemother; 2010 May; 54(5):1855-63. PubMed ID: 20231390
[TBL] [Abstract][Full Text] [Related]
16. Predominant bacteria and patterns of antibiotic susceptibility in urinary tract infection in children with spina bifida.
Ortiz TK; Velazquez N; Ding L; Routh JC; Wiener JS; Seed PC; Ross SS
J Pediatr Urol; 2018 Oct; 14(5):444.e1-444.e8. PubMed ID: 29709445
[TBL] [Abstract][Full Text] [Related]
17. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.
Håversen LA; Engberg I; Baltzer L; Dolphin G; Hanson LA; Mattsby-Baltzer I
Infect Immun; 2000 Oct; 68(10):5816-23. PubMed ID: 10992490
[TBL] [Abstract][Full Text] [Related]
18. Crude polysaccharides from the seeds of Vaccaria segetalis prevent the urinary tract infection through the stimulation of kidney innate immunity.
Mao X; Guo H; Yao R; Bao L; Sun J; Bao Y; Guo B; Gao Y; Shi Y; Zhang H; Cui X
J Ethnopharmacol; 2020 Oct; 260():112578. PubMed ID: 31962152
[TBL] [Abstract][Full Text] [Related]
19. Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat.
Jakobsen L; Garneau P; Bruant G; Harel J; Olsen SS; Porsbo LJ; Hammerum AM; Frimodt-Møller N
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1121-9. PubMed ID: 22033854
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
